Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001087294-26-000020
Filing Date
2026-03-09
Accepted
2026-03-06 20:54:38
Documents
116
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cpix-20251231.htm   iXBRL 10-K 1838672
2 EX-10.11 ex1011-ajkazimixemployment.htm EX-10.11 39477
3 EX-10.12 ex1012-jimhermanxemploymen.htm EX-10.12 40033
4 EX-10.13 ex1013-toddanthonyxemploym.htm EX-10.13 39174
5 EX-10.14 ex1014-chrisbittermanxempl.htm EX-10.14 39420
6 EX-10.15 ex1015-johnhammxemployment.htm EX-10.15 38749
7 EX-23.1 a2312025consentofaccountin.htm EX-23.1 2205
8 EX-31.1 a2025-10kxexhibit311.htm EX-31.1 12576
9 EX-31.2 a2025-10kxexhibit312.htm EX-31.2 12058
10 EX-32.1 a2025-10kxexhibit321.htm EX-32.1 6423
16 cpix-20251231_g1.jpg GRAPHIC 107115
  Complete submission text file 0001087294-26-000020.txt   10467090

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20251231.xsd EX-101.SCH 76210
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20251231_cal.xml EX-101.CAL 106672
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20251231_def.xml EX-101.DEF 304783
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20251231_lab.xml EX-101.LAB 882981
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20251231_pre.xml EX-101.PRE 626536
119 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20251231_htm.xml XML 1270500
Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 621765329 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 26732939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)